FR2450607A2 - Composition pharmaceutique contenant comme principe actif la flavopereine - Google Patents
Composition pharmaceutique contenant comme principe actif la flavopereineInfo
- Publication number
- FR2450607A2 FR2450607A2 FR7905853A FR7905853A FR2450607A2 FR 2450607 A2 FR2450607 A2 FR 2450607A2 FR 7905853 A FR7905853 A FR 7905853A FR 7905853 A FR7905853 A FR 7905853A FR 2450607 A2 FR2450607 A2 FR 2450607A2
- Authority
- FR
- France
- Prior art keywords
- flavopereirine
- antitumour
- anticancer
- compsn
- antiviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'INVENTION CONCERNE UNE NOUVELLE COMPOSITION PHARMACEUTIQUE CONTENANT COMME PRINCIPE ACTIF LA FLAVOPEREINE. ELLE POSSEDE UNE ACTION PREFERENTIELLE SUR LA REPLICATION DES ADN ET LA SYNTHESE DES ARN DES CELLULES TUMORALES, CANCEREUSES ET VIRALES.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7905853A FR2450607A2 (fr) | 1978-03-13 | 1979-03-07 | Composition pharmaceutique contenant comme principe actif la flavopereine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7807155A FR2419725A1 (fr) | 1978-03-13 | 1978-03-13 | Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales |
FR7905853A FR2450607A2 (fr) | 1978-03-13 | 1979-03-07 | Composition pharmaceutique contenant comme principe actif la flavopereine |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2450607A2 true FR2450607A2 (fr) | 1980-10-03 |
FR2450607B2 FR2450607B2 (fr) | 1982-10-22 |
Family
ID=26220482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7905853A Granted FR2450607A2 (fr) | 1978-03-13 | 1979-03-07 | Composition pharmaceutique contenant comme principe actif la flavopereine |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2450607A2 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0059817A1 (fr) * | 1981-03-11 | 1982-09-15 | Mirko Beljanski | Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales |
JPS57159712A (en) * | 1981-03-24 | 1982-10-01 | Beljanski Mirko | Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug |
FR2639830A1 (fr) * | 1988-12-02 | 1990-06-08 | Beljanski Mirko | Composition antivirale et ses applications |
WO1994002146A1 (fr) * | 1992-07-28 | 1994-02-03 | Abraxas Bio Labs Sa | Composition pharmaceutique a base de flavopereirine et son utilisation dans un traitement contre le virus vih |
WO2005112964A1 (fr) * | 2004-05-19 | 2005-12-01 | Natural Source International | Combinaisons de flavopereirine et d'alstonine dans le traitement et la prevention du cancer de la prostate |
US11083714B2 (en) | 2018-03-31 | 2021-08-10 | Molecular International Research, Inc. | Selective anti-cancer agent effective for prevention and treatment |
-
1979
- 1979-03-07 FR FR7905853A patent/FR2450607A2/fr active Granted
Non-Patent Citations (2)
Title |
---|
CA1958 * |
EXBK/58 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0059817A1 (fr) * | 1981-03-11 | 1982-09-15 | Mirko Beljanski | Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales |
JPS57159712A (en) * | 1981-03-24 | 1982-10-01 | Beljanski Mirko | Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug |
FR2639830A1 (fr) * | 1988-12-02 | 1990-06-08 | Beljanski Mirko | Composition antivirale et ses applications |
EP0373986A1 (fr) * | 1988-12-02 | 1990-06-20 | Abraxas Bio Labs S.A. | Composition antivirale et ses applications |
WO1994002146A1 (fr) * | 1992-07-28 | 1994-02-03 | Abraxas Bio Labs Sa | Composition pharmaceutique a base de flavopereirine et son utilisation dans un traitement contre le virus vih |
US5519028A (en) * | 1992-07-28 | 1996-05-21 | Beljanski; Mirko | Antiviral preparations |
WO2005112964A1 (fr) * | 2004-05-19 | 2005-12-01 | Natural Source International | Combinaisons de flavopereirine et d'alstonine dans le traitement et la prevention du cancer de la prostate |
US7341749B2 (en) * | 2004-05-19 | 2008-03-11 | Natural Source International Ltd. | Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer |
US11083714B2 (en) | 2018-03-31 | 2021-08-10 | Molecular International Research, Inc. | Selective anti-cancer agent effective for prevention and treatment |
Also Published As
Publication number | Publication date |
---|---|
FR2450607B2 (fr) | 1982-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7602317L (sv) | 1,4-dihydropyridinkarbonsyraalkylestrar till anvendning som lekemedel och sett att framstella desamma | |
ES8900006A1 (es) | Un procedimiento para preparar un complejo de inmunogeno | |
DK0397060T3 (da) | Maleinimidderivater og deres anvendelse som lægemidler | |
AU8199782A (en) | Phosphoramidite derivatives of nucleotides and their use in preparation of oligonucleotides | |
LU90131I2 (fr) | Interferon bêta - 1a et ses dérivés pharmaceutiquement acceptables (avonex) | |
IT1066689B (it) | Procedimento per produrre pezzi stampati di carburo di silicio e pezzi cosi prodotti | |
GR3003503T3 (fr) | ||
FR2450607A2 (fr) | Composition pharmaceutique contenant comme principe actif la flavopereine | |
DE3873581D1 (de) | Nitroglycerinarzneimittelpraeparat fuer perkutane absorption. | |
CA2145585A1 (fr) | N-oxydes et derives du chlorambucil utiles pour le traitement des cellules de tumeurs hypoxiques | |
AU611113B2 (en) | Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds | |
ATA395977A (de) | Digitale bremssteuereinrichtung zur vermeidung des blockierens der fahrzeugraeder eines kraftfahrzeuges | |
DK188286A (da) | Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser | |
CA2032254A1 (fr) | Derives de glycerol, mode de preparation et compositions therapeutiques en contenant | |
OA06083A (fr) | Nouvelles pipérazines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant. | |
HUP0302971A2 (hu) | (2-Azabiciklo[2.2.1]hept-7-il)-metanol-származékok, eljárás az előállításukra és nikotinos acetilkolin-receptorok agonistájakénti alkalmazásuk | |
ATE1150T1 (de) | Anthracyclinglycosiden, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen. | |
JPS52151114A (en) | Preparation of dimethylforamide | |
ES2083489T3 (es) | Derivados antracenicos de uso terapeutico y compuestos farmaceuticos que los contienen. | |
DK0466586T3 (da) | Disubstituerede polymethyleniminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
GB2000029A (en) | Anthraquinones for Cancer Therapy | |
SU645220A1 (ru) | Держатель электронных ламп | |
JPS5251373A (en) | Preparaton of pyrmidine ucleosides | |
FR2416228A1 (fr) | Sulfures de 4-pyrimidyle, leur procede de preparation et leur application en therapeutique | |
Fouron | Synthesis and reactions of 2', 3'-anhydronucleosides (nucleoside ribo and lyxo epoxides) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
TP | Transmission of property | ||
TP | Transmission of property | ||
SN | Distraint notified (in the national patent register) | ||
JU | Final juridical decision affecting the ownership or exploitation of an industrial property right | ||
ML | Cancellation of distraint | ||
TP | Transmission of property |